Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-15 11:43 AM View:  | Creech Timothy J See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 21,372 | $173.00 | $3,697,360.00 | (84%) 25.44K to 4.07K | |
| 03-Apr-15 11:36 AM View: | Bertrand William C Jr See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 28,289 | $173.00 | $4,894,000.00 | (91%) 31.26K to 2.97K | |
| 03-Apr-15 11:45 AM View: | D Alonzo Thomas Acting President and CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 18,290 | $173.00 | $3,164,170.00 | (100%) 18.29K to 0 | |
| 03-Apr-15 11:32 AM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 294,120 | $173.00 | $50,882,800.00 | (91%) 322.76K to 28.64K | |
| 03-Apr-15 11:40 AM View: | Keane William P Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 6,370 | $173.00 | $1,102,010.00 | (16%) 39.16K to 32.79K | |
| 03-Apr-15 11:43 AM View: | Creech Timothy J See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 4,065 | $173.00 | $703,245.00 | (100%) 4.07K to 0 | |
| 03-Apr-15 11:36 AM View: | Bertrand William C Jr See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 2,969 | $173.00 | $513,637.00 | (100%) 2.97K to 0 | |
| 03-Apr-15 11:45 AM View: | D Alonzo Thomas Acting President and CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 21,032 | $173.00 | $3,638,540.00 | (18%) 113.88K to 92.84K | |
| 03-Apr-15 11:53 AM View: | Forbes William P President, Medical, R&D & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 51,714 | $173.00 | $8,946,520.00 | (100%) 51.71K to 0 | |
| 03-Apr-15 11:58 AM View: | Scruggs Rick D Executive Vice President | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 48,006 | $173.00 | $8,305,040.00 | (64%) 74.96K to 26.96K | |
| 03-Apr-15 11:40 AM View: | Keane William P Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 32,790 | $173.00 | $5,672,670.00 | (100%) 32.79K to 0 | |
| 03-Apr-15 11:29 AM View: | Sirgo Mark A Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 6,370 | $173.00 | $1,102,010.00 | (17%) 37.43K to 31.06K | |
| 03-Apr-15 11:58 AM View: | Scruggs Rick D Executive Vice President | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 26,956 | $173.00 | $4,663,390.00 | (100%) 26.96K to 0 | |
| 03-Apr-15 11:32 AM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 28,644 | $173.00 | $4,955,410.00 | (100%) 28.64K to 0 | |
| 03-Apr-15 11:29 AM View: | Sirgo Mark A Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 31,057 | $173.00 | $5,372,860.00 | (100%) 31.06K to 0 | |
| 03-Apr-15 11:45 AM View: | D Alonzo Thomas Acting President and CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 74,555 | $173.00 | $12,898,000.00 | (80%) 92.84K to 18.29K | |
| 11-Mar-15 4:41 PM View: | Forbes William P President, Medical R&D and CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 09-Mar-15 | Private Sale | 42,880 | $157.84 | $6,768,180.00 | (45%) 94.59K to 51.71K | |
| 13-Mar-15 4:28 PM View: | Keane William P Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 09-Mar-15 | Gift | 600 | -- | -- | (2%) 39.76K to 39.16K | |
| 09-Mar-15 1:40 PM View: | Creech Timothy J See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-15 | Private Sale | 4,600 | $157.67 | $725,269.00 | (15%) 30.04K to 25.44K | |
| 09-Mar-15 5:01 PM View: | Scruggs Rick D Executive Vice President | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-15 | Private Sale | 4,000 | $157.55 | $630,200.00 | (5%) 78.96K to 74.96K | |
| 09-Mar-15 4:56 PM View: | Forbes William P EVP Research&Devel & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-15 | Private Sale | 20,000 | $157.96 | $3,159,200.00 | (17%) 114.59K to 94.59K | |
| 09-Mar-15 1:40 PM View: | Creech Timothy J See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 06-Mar-15 | Gift | 500 | -- | -- | (2%) 30.54K to 30.04K | |
| 04-Feb-15 5:06 PM View: | D Alonzo Thomas Acting Chief Executive Officer Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Feb-15 | Grant | 14,662 | -- | -- | 15% 99.22K to 113.88K | |
| 03-Feb-15 4:15 PM View: | Bertrand William C Jr See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 31-Jan-15 | Grant | 2,851 | -- | -- | 10% 28.41K to 31.26K | |
| 08-Jan-15 5:01 PM View: | Scruggs Rick D Executive Vice President | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-15 | Payment of Exercise | 8,408 | $114.94 | $966,416.00 | (10%) 87.37K to 78.96K | (5%) |
| 08-Jan-15 5:20 PM View: | Creech Timothy J See Remarks | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-15 | Payment of Exercise | 3,248 | $114.94 | $373,325.00 | (10%) 33.78K to 30.54K | (5%) |
| 08-Jan-15 5:08 PM View: | Forbes William P EVP Research&Devel & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 02-Jan-15 | Payment of Exercise | 10,997 | $114.94 | $1,264,000.00 | (9%) 125.59K to 114.59K | (5%) |
| 23-Dec-14 4:37 PM View: | Logan Carolyn J President & CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Dec-14 | Option Exercise | 44,000 | $17.63 | $775,720.00 | 4% 1.06M to 1.1M | |
| 26-Nov-14 4:04 PM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 24-Nov-14 | Option Exercise | 15,000 | $17.63 | $264,450.00 | 5% 307.76K to 322.76K | |
| 14-Nov-14 10:00 PM View: | Forbes William P EVP Research&Devel & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 12-Nov-14 | Market Option Sale | 11,079 | $95.05 | $1,053,060.00 | (8%) 136.67K to 125.59K | (26%) |
| 14-Nov-14 10:00 PM View: | Forbes William P EVP Research&Devel & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 12-Nov-14 | Option Exercise | 17,450 | $17.57 | $306,524.00 | 15% 119.22K to 136.67K | |
| 14-Nov-14 10:00 PM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 12-Nov-14 | Gift | 4,500 | -- | -- | (1%) 312.26K to 307.76K | |
| 26-Aug-14 6:49 PM View: | D Alonzo Thomas Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 3,185 | $158.30 | $504,186.00 | 3% 96.03K to 99.22K | (24%) |
| 26-Aug-14 6:46 PM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 3,185 | $158.30 | $504,186.00 | 1% 309.08K to 312.26K | (24%) |
| 26-Aug-14 6:58 PM View: | Forbes William P EVP Research&Devel & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 19,809 | $158.30 | $3,135,760.00 | 20% 99.41K to 119.22K | (24%) |
| 26-Aug-14 7:01 PM View: | Keane William P Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 3,185 | $158.30 | $504,186.00 | 9% 36.58K to 39.76K | (24%) |
| 26-Aug-14 7:05 PM View: | Logan Carolyn J President & CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 46,684 | $158.30 | $7,390,080.00 | 5% 1.01M to 1.06M | (24%) |
| 26-Aug-14 7:08 PM View: | Scruggs Rick D Executive Vice President | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 18,559 | $158.30 | $2,937,890.00 | 27% 68.81K to 87.37K | (24%) |
| 26-Aug-14 7:12 PM View: | Sirgo Mark A Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 3,185 | $158.30 | $504,186.00 | 9% 34.24K to 37.43K | (24%) |
| 26-Aug-14 6:54 PM View: | Derbyshire Adam C EVP Finance/CFO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 22-Aug-14 | Grant | 20,763 | $158.30 | $3,286,780.00 | 11% 197.7K to 218.46K | (24%) |
| 19-Aug-14 5:08 PM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 15-Aug-14 | Gift | 224,944 | -- | -- | (39%) 572.41K to 347.47K | |
| 19-Aug-14 5:08 PM View: | Chappell John F Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 15-Aug-14 | Gift | 24,944 | -- | -- | 5% 547.47K to 572.41K | |
| 03-Jul-14 9:46 PM View: | Forbes William P EVP Research&Devel & CDO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-14 | Payment of Exercise | 1,971 | $123.35 | $243,123.00 | (2%) 101.38K to 99.41K | 3% |
| 03-Jul-14 4:24 PM View: | Logan Carolyn J President & CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-14 | Payment of Exercise | 8,253 | $123.35 | $1,018,010.00 | (< 1%) 1.02M to 1.01M | 3% |
| 03-Jul-14 9:38 PM View: | Derbyshire Adam C EVP Finance/CFO | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-14 | Payment of Exercise | 2,458 | $123.35 | $303,194.00 | (1%) 200.16K to 197.7K | 3% |
| 03-Jul-14 4:11 PM View: | Scruggs Rick D Executive Vice President | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Jul-14 | Payment of Exercise | 1,243 | $123.35 | $153,324.00 | (2%) 70.05K to 68.81K | 3% |
| 30-Jun-14 4:37 PM View: | Logan Carolyn J President & CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 26-Jun-14 | Option Exercise | 99,375 | $18.87 | $1,875,210.00 | 10% 975.09K to 1.07M | |
| 30-Jun-14 4:37 PM View: | Logan Carolyn J President & CEO Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 26-Jun-14 | Market Option Sale (Planned) | 53,057 | $123.38 | $6,546,370.00 | (5%) 1.07M to 1.02M | 3% |
| 17-Jun-14 4:25 PM View: | D Alonzo Thomas Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 13-Jun-14 | Payment of Exercise | 1,439 | $113.80 | $163,758.00 | (1%) 97.47K to 96.03K | (6%) |
| 17-Jun-14 4:35 PM View: | Keane William P Director | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 13-Jun-14 | Payment of Exercise | 1,850 | $113.80 | $210,530.00 | (5%) 38.42K to 36.58K | (6%) |
